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Abstract
Background: Estrogen influences susceptibility to migraine attacks and it has been suggested to affect jealousy in
romantic relationships in women. Therefore, we hypothesized that migraine women may be more jealous.
Methods: Jealousy levels and hormonal status were determined based on a cross-sectional, web-based,
questionnaire study among female migraine patients and controls. A random sample of participants was selected
from a validated migraine database. Participants with a serious and intimate monogamous relationship were
included (n = 498) and divided into the following subgroups: menstrual migraine (n = 167), non-menstrual migraine
(n = 103), postmenopausal migraine (n = 117), and premenopausal (n = 57) and postmenopausal (n = 54) controls.
The primary outcome was the difference in mean jealousy levels between patients with menstrual migraine, non-
menstrual migraine and premenopausal controls. Results were analyzed with a generalized linear model adjusting
for age, relationship duration and hormonal status (including oral contraceptive use). Additionally, the difference in
jealousy levels between postmenopausal migraine patients and controls was assessed. Previous research was
replicated by evaluating the effect of combined oral contraceptives on jealousy.
Results: Jealousy levels were higher in menstrual migraine patients compared to controls (mean difference ± SE:
3.87 ± 1.09, p = 0.001), and non-menstrual migraine patients compared to controls (4.98 ± 1.18, p < 0.001). No
difference in jealousy was found between postmenopausal migraine patients and controls (− 0.32 ± 1.24, p = 0.798).
Women using combined oral contraceptives were more jealous compared to non-users with a regular menstrual
cycle (2.32 ± 1.03, p = 0.025).
Conclusion: Young women with migraine are more jealous within a romantic partnership.
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Background
Sex hormones have a major influence on migraine,
appearing from a three times higher migraine prevalence
in premenopausal women compared to men, an increase
in attack frequency during menopausal transition, and a
postmenopausal decrease of symptoms [1–3].
Furthermore, the fluctuation of estrogen prior to men-
struation is evidently linked to an increased susceptibility
to an upcoming attack [4]. Two subtypes of migraine
with menstruation-associated attacks exist: pure men-
strual migraine (PMM) and menstrually-related migraine
(MRM). In MRM, attacks occur additionally at other
times of the cycle. For research purposes, PMM and
MRM are often taken together and defined as menstrual
migraine (MM) [5]. Although the exact pathophysio-
logical underlying mechanism remains unclear, previous
research has suggested that fluctuations in estrogen
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levels, possibly the rate of decrease in estrogen, may
affect the susceptibility to migraine attacks in women
and/or higher estrogen levels may be implicated in both
sexes [2, 6–9].
Problems within a romantic relationship, such as jeal-
ousy, divorce, and bereavement after the suicide of a
partner potentially have a large impact on quality of life
[10, 11]. Knowledge on potential associations between
relationship problems and disabling chronic diseases,
such as migraine, may increase our understanding, re-
duce stigma, and improve disease outcomes. Relation-
ship jealousy can be defined as thoughts, emotions, or
behaviors that occur as a result of the perceived threat
of losing a partner to an actual or imagined rival [12]. In
the fertile phase, when estrogen levels are high, women
tend to report higher jealousy levels compared to other
times of the menstrual cycle [13]. Furthermore, jealousy
seems to be affected by the use of combined oral contra-
ceptives. Especially using formulations with higher doses
of ethinyl estradiol are associated with significantly
higher jealousy scores [13–15]. These findings indicate
that estrogen plays a role in jealousy within a romantic
relationship, but the exact underlying mechanism is
unknown.
That biological factors may affect mental health has
been illustrated by previous research concluding that al-
terations in prolactin and thyroid hormone levels are as-
sociated with suicide attempts in psychiatric patients
[16].
We hypothesized that women with migraine, especially
those fulfilling the criteria of MM, would have higher
jealousy levels compared to women with non-menstrual
migraine (non-MM) and premenopausal controls due to
a corresponding provoking effect of estrogen in migraine
and jealousy. Secondarily, we hypothesized that post-
menopausal migraineurs and controls report low and
similar jealousy levels due to stabilization of sex hor-
mones [3, 17]. Lastly, we investigated the effect of using
combined oral contraceptives on jealousy, aiming to rep-
licate previous results on this topic.
Methods
Study design
This study is a cross-sectional, web-based, questionnaire
study among female migraine patients and healthy con-
trols, performed in November and December 2018.
Participants
The Leiden University Medical Center MIgraine Neuro
Analysis (LUMINA) cohort was used to select women
who met the ICHD-3 criteria for migraine and healthy
controls [5]. An elaborate description of LUMINA par-
ticipants and procedures is found in a previous publica-
tion and in Additional file 1 [18]. The study was
approved by the medical ethics committee of Leiden
University Medical Center. All subjects provided written
informed consent prior to the study. A random selection
of n = 1024 female migraine patients and controls was
made from the LUMINA cohort for this present study.
As inclusion criterium participants were required to
have a serious and intimate monogamous relationship,
assuming that contributions are equally divided among
the partners and both partners have a concern for the
welfare of the other, and will therefore respond to each
other’s needs [19]. Pregnant and breastfeeding women
were excluded. Additionally, women with a permanent
primary amenorrhea, and therefore lifelong absence of
menses, were excluded. Participants received a web-
based questionnaire consisting of questions concerning
relationship duration, jealousy feelings and thoughts,
menstrual cycle status and exogenous sex hormone use.
Jealousy scores were determined using the validated
Buunks Jealousy scale (Cronbach’s alpha = 0.843) [12].
This questionnaire consists of five statements for each of
the three sub-types of jealousy, i.e. reactive jealousy (a
negative response to the emotional or sexual involve-
ment of the partner with someone else), preventive jeal-
ousy (efforts to prevent intimate contact of the partner
with someone else) and anxious jealousy (obsessive anx-
iety and worrying about the possibility of infidelity of the
partner). A 5-point Likert scale was used to rate how
strongly the participants agreed with the statements.
Premenopausal migraine patients were categorized as
MM or non-MM according to the ICHD-3 criteria [5].
Covariates
The covariates age, relationship duration and hormonal
status were chosen a-priori based on previous studies.
Relationship duration was categorized as shorter or lon-
ger than 1 year. Although the effect of relationship dur-
ation on jealousy levels is inconsistent in previous
studies, this covariate was reasoned to be important, and
therefore, was included in this study [20, 21]. Hormonal
status was defined as the use of combined oral contra-
ceptives (COC), use of other hormonal contraceptives or
no use of hormonal contraceptives (i.e. naturally men-
struating). Other hormonal contraceptives included
desogestrel-only pills, levonorgestrel intrauterine devices,
etonogestrel subcutaneous implants, medroxyprogester-
one injections and an ethinylestradiol/etonogestrel ring.
The naturally menstruating group consisted of women
with a regular menstrual cycle (i.e. duration of 21 to 35
days) or irregular menstrual cycle (i.e. shorter than 21
days, longer than 35 days or irregular). The use of hor-
monal contraceptives has been shown to increase jeal-
ousy levels and was an important covariate to include in
our analyses [13, 14].
van Casteren et al. The Journal of Headache and Pain           (2020) 21:51 Page 2 of 8
Statistical analyses
One-way ANOVA or Chi-square tests were used to
compare the characteristics between the different
groups. For our primary analysis we performed a gener-
alized linear model to assess the mean difference be-
tween the total self-reported jealousy scores of MM,
non-MM and premenopausal controls. Age, relationship
duration and hormonal status were included as covari-
ates. In a secondary analysis, we compared the mean
total jealousy levels of postmenopausal migraine patients
and controls using a generalized linear model, adjusting
for age and relationship duration. The same statistical
model was used to compare mean jealousy levels be-
tween women using COC and women with a regular
menstrual cycle, controlling for age, relationship dur-
ation and migraine status. Mean differences in sub-type
jealousy levels were analyzed for the premenopausal
groups as exploratory analyses. A p-value of < 0.05 was
considered statistically significant.
Results
Participants
A total of 1024 women were invited to participate in this
study, of which 498 were eligible and completed the
questionnaire (see Fig. 1).
The characteristics of the premenopausal and post-
menopausal study populations are shown in Tables 1
and 2, respectively. The majority of premenopausal mi-
graine patients was classified as MM (62%), of which
38% fulfilled the criteria of migraine with aura. In the
non-MM group, 60% of patients had migraine with aura.
The number of migraine days per month was higher in
women with MM compared to women with non-MM,
with at least one migraine day per week in 38% of the
MM group compared to 20% in the non-MM group. In
the postmenopausal migraine group, 39% experienced at
least one migraine day per week.
Premenopausal controls and MM patients were more
likely to have a regular menstrual cycle than to use hor-
monal contraceptives. Non-MM patients more fre-
quently used combined oral contraceptives or other
hormonal contraceptives. Migraine and/or headache was
in 38% of MM patients and in 30% of non-MM patients
a reason to start using combined oral contraceptives.
MM patients mentioned more frequently headache and/
or migraine as reason for starting other hormonal con-
traceptives compared to non-MM patients (respectively
61% and 45%). Furthermore, women with MM were
more likely to be irregularly cycling (20%) compared to
controls (9%) and non-MM patients (7%).
Fig. 1 Flow diagram of recruitment of participants
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Women using combined oral contraceptives (COC)
were younger than women who were regularly cycling
(mean 34.9 and 38.5 years, respectively). The percentage
of women with a relationship duration of at least 1 year
in the COC group was 89%, which was comparable to
the group with a regular menstrual cycle (96%). Further-
more, 82% of participants in the COC group had mi-
graine, compared to 79% of the women with a regular
menstrual cycle.
Primary analysis
There was a significant difference in mean total self-
reported jealousy levels between MM, non-MM and
premenopausal control groups, X2 (2)= 18.05, p < 0.001.
After adjusting for age, relationship duration and hor-
monal status, the difference between groups remained
statistically significant, X2 (2)= 18.67, p < 0.001. A pair-
wise comparison with Bonferroni correction revealed
that the mean jealousy levels were higher in patients
with MM compared to controls (mean difference ± SE:
3.87 ± 1.09, p = 0.001), and in non-MM patients com-
pared to controls (4.98 ± 1.18, p < 0.001). There was no
difference in jealousy levels between the MM and non-
MM group (− 1.11 ± 0.93, p = 0.705) (see Fig. 2). Age was
negatively correlated with jealousy levels, resulting in a
decline of 0.49 points per 5 years, X2 (1) = 5.1, p = 0.024.
Table 1 Characteristics of the premenopausal study population
Control
(n = 57)
non-MM
(n = 103)
MM
(n = 167)
p-value
Age, y, mean (SD) 37.2 (9.7) 37.5 (10.3) 38.8 (9.3) 0.401
Relationship duration > 1 year, n (%) 50 (87.7) 89 (86.4) 160 (95.8) 0.015
BMI, mean (SD) 23.1 (3.7) 23.5 (4.1) 23.7 (4.0) 0.594
Menstrual cycle, n (%) 29 (50.9) 31 (30.1) 102 (61.1) < 0.001
Regular menstrual cycle 24 (42.1) 24 (23.3) 68 (40.7)
Irregular menstrual cycle 5 (8.8) 7 (6.8) 34 (20.4)
COC 15 (26.3) 30 (29.1) 37 (22.2)
Other hormonal contraceptive 13 (22.8) 42 (40.8) 28 (16.8)
Migraine frequency, n (%) < 0.001
≤ 1 day/month – 40 (38.8) 23 (13.8)
1–4 days/month – 42 (40.8) 80 (47.9)
≥ 5 days/month – 21 (20.4) 64 (38.3)
Type of migraine, n (%) < 0.001
Without aura – 41 (39.8) 103 (61.7)
With aura – 62 (60.2) 64 (38.3)
Non-MM non-menstrual migraine, MM menstrual migraine, COC combined oral contraceptive. A relationship is defined as a serious and intimate monogamous
relationship. A regular menstrual cycle is defined as a menstrual cycle duration of 21 to 35 days. Irregular menstrual cycle duration is defined as shorter than 21
days, longer than 35 days or an irregular duration
Table 2 Characteristics of the postmenopausal study population
Postmenopausal control
(n = 54)
Postmenopausa lmigraine
(n = 117)
p-value
Age, y, mean (SD) 59.9 (6.2) 58.1 (6.7) 0.093
Relationship duration > 1 year, n (%) 54 (100) 115 (98.3) 0.334
BMI, mean (SD) 24.8 (3.6) 24.6 (4.4) 0.731
Migraine frequency, n (%)
≤ 1 day/month – 26 (22.2)
1–4 days/month – 45 (38.5)
≥ 5 days/month – 46 (39.3)
Type of migraine, n (%) –
Without aura – 68 (58.1)
With aura 49 (41.9)
A relationship is defined as a serious and intimate monogamous relationship
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The homogeneity of variance, tested with a Levene’s test
of equality of error variances, was violated in this pri-
mary analysis (F (2,324) = 8.94, p < 0.001). However,
using a robust model did not alter the outcome, there-
fore no adjustments were made to correct for this
violation.
Secondary analyses
Mean total jealousy levels were similar in postmeno-
pausal migraine patients and controls (mean difference
± SE: -0.41 ± 1.23, p = 0.737). Adjusting for age and re-
lationship duration did not influence the outcome
(-0.32 ± 1.24, p = 0.798) (see Fig. 3). Women using COC
reported higher jealousy levels compared to women with
a regular menstrual cycle (2.32 ± 1.03, p = 0.025). After
adding age and relationship duration as covariates, this
effect became borderline significant (1.86 ± 1.04,
p = 0.073). Women with a relationship duration of at
least 1 year scored 4.9 points lower compared to women
with a relationship duration of less than 1 year, X2
(1) = 5.6, p = 0.018. The presence of migraine was asso-
ciated with an increase of 3.6 points in jealousy levels
(X2 (1) = 8.6, p = 0.003). However, adding migraine sta-
tus as covariate did not alter the overall effect of using
COC on jealousy levels (1.77 ± 1.02, p = 0.081) (Table
3). Migraine attack frequency was not added as covariate
as it did not affect jealousy levels in both, the total group
of migraine patients (X2 (5) = 3.14, p = 0.678) and the
subgroup of premenopausal migraine patients (X2 (5) =
5.53, p = 0.355).
Exploratory analyses
Mean differences in the three sub-type jealousy levels
(reactive jealousy, preventive jealousy and anxious jeal-
ousy) were analyzed for the premenopausal groups as
exploratory analyses. A pairwise comparison with Bon-
ferroni correction revealed that both MM and non-MM
groups reported higher levels compared to the premeno-
pausal control group for the reactive jealousy sub-type
(mean difference ± SE: 1.89 ± 0.64, p = 0.010 and 1.97 ±
0.70, p = 0.014, respectively). Similarly, both MM and
non-MM groups reported higher anxious jealousy levels
compared to premenopausal controls (1.24 ± 0.49, p =
0.035 and 1.83 ± 0.53, p = 0.002, respectively). No static-
ally significant difference was found in mean preventive
jealousy levels between premenopausal controls and
MM patients (− 0.74 ± 0.35, p = 0.104). Non-MM pa-
tients reported higher mean preventive jealousy scores
Fig. 2 Mean of total jealousy levels controlled for age, relationship
duration and hormonal status. Legend: Premenopausal women:
MM =menstrual migraine; non-MM= non-menstrual migraine;
Premenopausal non-migraine controls. Jealousy levels were
determined using the validated Buunks Jealousy scale (score
between 15 and 75). Depicted levels are mean ± SEM.* = statistically
significant difference, n.s. = non-statistically significant difference
Fig. 3 Mean of total jealousy levels controlled for age and
relationship duration. Legend: Postmenopausal women:
Postmenopausal migraine patients; Postmenopausal non-migraine
controls. Jealousy levels were determined using the validated
Buunks Jealousy scale (score between 15 and 75). Depicted levels
are mean ± SEM. n.s. = non-statistically significant difference
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compared to premenopausal controls (1.18 ± 0.38, p =
0.005).
Discussion
Premenopausal women with migraine in a relationship
have significantly higher jealousy scores than controls in
this study. This is independent from whether they ex-
perience menstrually-related attacks and the effect disap-
pears after menopause. Our hypothesis is that this
association between migraine and increased jealousy is
due to the effect of estrogen. Previous research showed
estrogen levels to be higher in women with MM com-
pared to controls during most phases of the menstrual
cycle, and with only small differences between MM and
non-MM patients [7, 8]. As estrogen levels will be low in
the postmenopausal stage of life we expected that differ-
ence in jealousy levels would diminish and indeed we
did not find differences when comparing postmeno-
pausal female migraine patients with controls supporting
our hypothesis. Interestingly, we did not find a signifi-
cant difference in jealously between patients with
menstrually-related attacks (MM) and those without
menstrually-related attacks (non-MM). We imagine that
there might be one important explanation for this,
namely the inaccuracy of non-diary self-reported MM or
non-MM diagnosis. In a recent study, we asked 104 fe-
male migraine patients whether their attacks were asso-
ciated with the menstruation and then collected
prospective e-diaries. In this study, we showed women’s
self-reported diagnoses had a positive predictive value of
65% and negative predictive value of 50%. Sensitivity was
80% and specificity 33% [22]. Accurate MM diagnoses
are difficult to obtain even when prospective diaries are
collected. Previous research has shown that current
ICHD-3 diagnostic criteria for MM reached maximum
sensitivity only for three menstrual cycles, although spe-
cificity increased with more cycles of data collection
[23]. Thus, accuracy of self-reported menstrual-related
migraine diagnosis is poor in female migraine patients
and we suggest to reconsider the ICHD-3 criteria for
menstrual migraine where no prospective diary data is
required anymore to confirm MM.
Are there alternative explanations for our findings?
The effect of a disabling chronic disease on the quality
of life might explain the higher jealousy response within
romantic relationships in female migraine patients. The
most recent Global Burden of Disease study ranked mi-
graine as the second most disabling disease worldwide
[24]. Previous studies showed that migraine patients
scored lower on health-related quality of life domains
than controls, such as social functioning and mental
health [25, 26]. Female migraine patients might have less
social interaction compared to their partners, both dur-
ing a migraine attack due to severe headache and disab-
ling associated symptoms, but also outside migraine
attacks due to an adjusted lifestyle trying to prevent mi-
graine attacks. One could imagine that a disbalance in
social interactions in a romantic relationship may induce
jealousy towards a partner. Studying the association be-
tween other disabling chronic diseases and jealousy
within romantic relationships may be of interest in this
light. Although postmenopausal women with migraine
are limited in social activities, their jealousy response is
comparable to that of postmenopausal controls, suggest-
ing that impaired social functioning only partially con-
tributes to the difference in jealousy between younger
migraine patients and controls. Several population-based
studies have analysed the prevalence of disabling pain
disorders and associated risk factors. Separated or di-
vorced status is consistently associated with an increased
risk of (chronic) pain in women [27–29]. Additionally,
separation and divorce have been suggested to be a risk
factor for worsening outcomes in pain disorders with
persisting pain [30]. This knowledge might be helpful in
understanding the potential adverse effects of migraine
on the relationships of patients, such as jealousy and po-
tentially divorce.
A recent meta-analysis on personality of migraine pa-
tients has shown higher risk for neuroticism and harm
avoidance, and for low self-directedness and extraversion
in migraineurs [31], which hypothetically may be in-
volved in more pronounced reactive and anxious jeal-
ousy scores than preventive scores for MM patients.
Women using combined oral contraceptives reported
higher jealousy compared to non-using women with a
regular menstrual cycle, which is congruent with previous
studies [13, 20]. With this, our study contributes to the
existing literature by using a different study population
and adjusting for relevant covariates, which limits poten-
tial confounders and increases the validity. Participants in
our study were older and had a longer relationship dur-
ation compared to participants in other studies, who were
Table 3 Comparison of jealousy levels between women using COCs and women with a regular menstrual cycle
Combined oral contraceptive
(n = 82)
Regular menstrual cycle
(n = 116)
p-value
Unadjusted (mean ± SE) 34.3 ± 0.79 31.9 ± 0.67 0.025
Adjusted for age and relationship duration (mean ± SE) 36.1 ± 1.16 34.2 ± 1.13 0.073
Adjusted for age, relationship duration and migraine status (mean ± SE) 35.1 ± 1.18 33.4 ± 1.14 0.081
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students with a mean age of 22 years and a mean relation-
ship duration of 1 year [13, 20]. The higher jealousy levels
in women using combined oral contraceptives might be
caused by an effect of estrogen, which is suggested to in-
fluence jealous behavior [14, 15]. Progesterone dose in
combined oral contraceptives is shown to be unrelated to
reported jealousy, but combined oral contraceptives with
higher doses of ethinyl estradiol are associated with higher
jealousy compared with formulations with lower ethinyl
estradiol doses [14, 15].
This study has a number of strengths. A large number
of participants from the reliable LUMINA cohort were
recruited. Furthermore, a validated jealousy scale was
used, with a Cronbach’s alpha of 0.843 indicating a very
good internal consistency. However, some limitations of
our study should be mentioned. Firstly, a considerable
part of invited women were classified as non-responders.
The non-response rate could partially be explained by
women who were not eligible for participation, e.g. as
they had no romantic partnership at the time of the
study but refrained from informing the investigators.
Secondly, as indicated the MM and non-MM diagnoses
in this study were not based on diary data as this is not
a requirement anymore in the ICHD-3 classification. In
addition, the phase of the menstrual cycle at the time of
completing the questionnaire is unknown. In a prior
study, higher jealousy levels were found in the fertile
phase compared to the non-fertile phase of the men-
strual cycle. However, this effect became marginally sig-
nificant when comparing the menstrual cycle phases in
partnered women [13]. Since we included only partnered
women, this is thus thought to be of less importance for
our results. Additionally, since the percentage of women
with a regular menstrual cycle in the MM and control
group is comparable (41% vs. 42% respectively), the
amount of women in the fertile and non-fertile phase is
expected to be equally distributed in these groups.
Conclusions
Our study is the first to show that young migraine
women are more jealous within a romantic partnership
than non-migraine women. We suggest estrogen to play
an important role in this relationship. Future research is
needed on establishing the role of estrogen in women
with migraine as this may provide important treatment
options for this incapacitating disorder. We encourage
physicians treating patients with migraine to pay atten-
tion to aspects of social functioning.
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